spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Novo Nordisk 

 HSMN NewsFeed - 23 Jul 2024
Magenta Medical Closes $105M Financing Led by Novo Holdings
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 18 Jul 2023
Flagship Pioneering and Pfizer Partner to Accelerate Development of Innovative Medicines Targeting Unmet Needs
Biopharmaceuticals
 HSMN NewsFeed - 18 Jan 2023
NeuroBo Pharmaceuticals Appoints Joseph Hooker as Interim Chief Executive Officer and President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Sep 2022
Nouscom Strengthens Leadership Team with the Appointments of Sven Gogov, MD, as Chief Medical Officer and Maria Arce-Tomas, PhD, as VP, Head of Regulatory Affairs
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 27 Jun 2022
INOVIO Appoints Dr. Michael Sumner, MB BS, MBA as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jul 2021
Hemab Raises US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 24 May 2021
Stemedica Signs License Agreement with Pulthera, LLC for all Respiratory Indications including those related to COVID-19
Regenerative Medicine Licensing
 HSMN NewsFeed - 9 Feb 2021
Lannett Expands Strategic Relationship To Include Biosimilar Fast-Acting Insulin
Biopharmaceuticals Endocrinology Generics
 HSMN NewsFeed - 17 Sep 2020
Novo Ventures co-leads US $83m series C financing in Lava Therapeutics
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 3 Jun 2020
Novo Ventures Leads US$55M Series B Investment in NodThera
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 May 2020
Acesion Pharma Strengthens Clinical Team With Key Appointments
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 20 Dec 2019
Lodo Therapeutics Names Serial Biotech Entrepreneur Dale Pfost As CEO And Adds Top Industry Veterans To Leadership Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 29 Oct 2019
Disc Medicine Completes $50 Million Series A Financing led by Novo Holdings A/S to Advance New Therapies Addressing Ineffective Red Blood Cell Production
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Sep 2019
Novo Seeds Co-leads €20 Million Series A Financing in STipe Therapeutics
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Sep 2019
Arix Bioscience plc: Arix Co-leads EUR 20 Million Series A Investment Round in STipe Therapeutics
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Aug 2019
Glycomine, Inc. Announces $33 Million Series B Financing to Advance its Therapy for a Congenital Disease of Glycosylation
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 23 Apr 2018
Dr. Philip Just Larsen Appointed Chief Scientific Officer (CSO)
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Mar 2018
FDA approves inclusion of data from safety outcomes trial in the Tresiba(R) label
Biopharmaceuticals Endocrinology Cardiology FDA
 HSMN NewsFeed - 8 Feb 2018
Novo Nordisk Launches Rebinyn(R) in the United States for People with Hemophilia B
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 14 Dec 2017
Companion Medical Announces U.S. Commercial Launch of Smart Insulin Pen System
Devices Drug Delivery Endocrinology Product Launch
 HSMN NewsFeed - 7 Dec 2017
Metacrine Completes Series B Financing to Advance Best-in-Class FXR Program into Clinical Development
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 1 Aug 2017
Milestone Pharmaceuticals Closes $55 Million Series C Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 9 Jan 2017
Macrophage Pharma Raises £9 Million in Series A Financing and Acquires Immune-oncology Technology Platform
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Nov 2016
Synthorx Appoints Patrick J. Doyle as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jan 2016
Novo Nordisk Launches Tresiba(R) (insulin degludec injection 200 Units/mL) in the United States
Biopharmaceuticals Endocrinology Product Launch
 HSMN NewsFeed - 14 Dec 2015
Enanta Pharmaceuticals Announces the Election of Bruce L.A. Carter, Ph.D. as Non-Executive Chairman of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Sep 2015
CeQur Announces $100 Million Series C Financing
Devices Drug Delivery Endocrinology Venture Capital
 HSMN NewsFeed - 31 Jul 2015
Xencor Appoints Yujiro S. Hata to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jul 2015
KalVista Pharmaceuticals Raises $33 Million to Advance Development of Novel Plasma Kallikrein Inhibitors in Diabetic Macular Edema and Hereditary Angioedema
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Apr 2014
Nora Therapeutics Announces $18 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Mar 2014
Caisson Biotech Expands HEPtune(TM) Drug Delivery Deal with Novo Nordisk
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 30 Jan 2014
Novo Nordisk Promotes Eddie Williams to Senior Vice President
Biopharmaceuticals Endocrinology Personnel
 HSMN NewsFeed - 30 Sep 2013
Alkermes Expands Senior Management Team
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 29 Aug 2013
ObsEva SA Announces CHF 32 Million Series A Funding From Leading Venture Capital Firms and a License Agreement With Merck Serono
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 21 Aug 2013
Novo Nordisk receives U.S. FDA clearance for the insulin injection device NovoPen Echo(R)
Biopharmaceuticals Devices Drug Delivery FDA
 HSMN NewsFeed - 26 Jul 2013
Adimab Announces First Antibody Technology Transfer and License Agreement with GlaxoSmithKline
Biopharmaceuticals Licensing
 HSMN NewsFeed - 17 Jul 2013
Intarcia Therapeutics Appoints Dr. Eddie Li Vice President and Global Head of Regulatory Affairs
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 29 May 2013
Ophthotech Raises $175 Million to Finance the Pivotal Phase 3 Program for Fovista(TM) Anti-PDGF Combination Therapy in Wet AMD
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 21 May 2013
Novo A/S acquires Xellia Pharmaceuticals for US$ 700 million
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Jan 2013
Bionor Pharma Appoints Anker Lundemose as President and Chief Executive Officer
Biopharmaceuticals HIV/AIDS Personnel
 HSMN NewsFeed - 22 Jan 2013
Ceterix Orthopaedics Completes $19.5 Million Series B Financing
Devices Orthopaedic Venture Capital
 HSMN NewsFeed - 4 Dec 2012
Flexion Therapeutics Secures $20 Million in Series B Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 30 Oct 2012
Thesan Pharmaceuticals Announces Series A Funding Co-Led By Novo Ventures And Novartis Venture Funds
Biopharmaceuticals Dermatology Venture Capital Personnel
 HSMN NewsFeed - 20 Jul 2012
Supernus Appoints Dr. Stefan Schwabe, MD, PhD as Exec. VP R&D and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 May 2012
FDA Approves Levemir(R) for Expanded Use in Children Two to Five Years of Age with Type 1 Diabetes
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 27 Apr 2012
Novo Nordisk plans 15 percent expansion of U.S. work force in 2012
Biopharmaceuticals
 HSMN NewsFeed - 18 Apr 2012
Favorable Ruling by United States Supreme Court on Prandin(R) Litigation
Biopharmaceuticals Endocrinology Generics Litigation
 HSMN NewsFeed - 2 Apr 2012
FDA Approves Levemir(R) Pregnancy Category Change for Women with Diabetes
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 19 Jan 2012
Astellas Pharma Europe Ltd. Appoints Mike Crooks to Head up its UK Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Sep 2011
Valeritas Announces $150 Million Financing
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 21 Apr 2011
Novo Nordisk Announces U.S. Launch of NovoTwist(R) for Use with Levemir(R) FlexPen(R), NovoLog(R) FlexPen(R) and Victoza(R) Pen Devices
Devices Drug Delivery Endocrinology
 HSMN NewsFeed - 20 Apr 2011
Urovalve appoints Bent Johnsen as European Managing Director
Devices Urology Personnel
 HSMN NewsFeed - 1 Mar 2011
Valeritas Receives FDA 510(k) Clearance for the V-Go Disposable Insulin Delivery Device for Use with NovoLog(R)
Devices Drug Delivery FDA
 HSMN NewsFeed - 17 Dec 2010
InterMune Announces Senior Leadership Appointments to Prepare for Launch of Esbriet (Pirfenidone) in Europe
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Sep 2010
Bristol-Myers Squibb to Acquire ZymoGenetics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 1 Sep 2010
Archimedes Pharma Receives European Marketing Authorisation for PecFent(R) for the Treatment of Breakthrough Cancer Pain
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 Aug 2010
Novo Nordisk Inc. Announces Exclusive Agreement With Upsher-Smith Laboratories, Inc. to Market Vagifem(R) 10 mcg
Biopharmaceuticals
 HSMN NewsFeed - 3 Mar 2010
Novo Nordisk Receives FDA Approval for Norditropin(R) FlexPro(R) for Growth Hormone Treatment
Biopharmaceuticals Devices Drug Delivery FDA
 HSMN NewsFeed - 26 Jan 2010
Novo Nordisk's Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 7 Dec 2009
Xencor Appoints Former ZymoGenetics CEO, Bruce Carter, to Chairman of the Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Aug 2009
Ventana Enters Into a Multi Billion Dollar Market
Biopharmaceuticals
 HSMN NewsFeed - 15 Jul 2009
FDA Approves NovoLog(R) Labeling Update
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 2 Jun 2009
Bionovo Appoints Dr. Klaus Kohl as Chief Technical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2009
Depomed Names Shay Weisbrich Vice President of Marketing
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 29 May 2009
Novo Nordisk: New study directly comparing insulin delivery devices shows that Next Generation FlexPen has a significantly lower injection force than SoloStar and KwikPen
Biopharmaceuticals Drug Delivery Endocrinology
 HSMN NewsFeed - 2 Apr 2009
Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 26 Feb 2009
FDA Approves Apidra(R) SoloSTAR(R) - a Prefilled Disposable Insulin Pen
Biopharmaceuticals Drug Delivery Endocrinology FDA
 HSMN NewsFeed - 25 Feb 2009
Proteolix Announces the Appointment of John Scarlett, M.D., President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Feb 2009
AspenBio Appoints Robert Caspari, M.D. as Chief Operating Officer and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jan 2009
Sangart, Inc. Announces Key Executive Appointments and Company Restructuring
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Nov 2008
FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Nov 2008
FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 25 Sep 2008
IVAX Diagnostics Announces Appointment of Paul F. Kennedy as Chief Executive Officer, President and Chairman of the Board
Diagnostics Personnel
 HSMN NewsFeed - 3 Sep 2008
Osprey Pharmaceuticals U.S.A., Inc. Completes $11 Million Initial Private Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Jul 2008
Christopher Kurtz Joins Alexza Pharmaceuticals as Vice President, Global Supply Chain and Sustainment Engineering
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jun 2008
FDA Approves PrandiMet(TM), a Replaglinide and Metformin Fixed-Dose Combination Tablet for Treatment of Type 2 Diabetes
Biopharmaceuticals FDA Endocrinology
 HSMN NewsFeed - 13 May 2008
FDA Approves NOVO NORDISK's NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With Inhibitors
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Apr 2008
Aradigm Announces Data Showing No Occurrence of Primary Lung Cancer in Patients Treated with AERx(R) Insulin Diabetes Management System (iDMS)
Biopharmaceuticals Drug Delivery Endocrinology
 HSMN NewsFeed - 27 Mar 2008
Pieris Raises EUR 25 M (US$ 38 M) in Series B Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Feb 2008
Novo Nordisk Consolidates U.S. Diabetes Sales Leadership Under Single Vice President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jan 2008
Novo Nordisk Appoints Alan C. Moses as Chief Medical Officer Worldwide
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Nov 2007
Antibody Engineering Company f-star Raises EUR 3.0 Million in a Second Closing of its Series A Financing Round From Novo A/S
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Nov 2007
Novo Nordisk Inc. Announces Exclusive Agreement With Sciele Pharma, Inc. to Market Prandin(R)
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 19 Nov 2007
Sciele Signs Exclusive Agreement with Novo Nordisk to Market Prandin(R) and PrandiMet(R)
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 25 Oct 2007
Aradigm Corporation Reports Initial Human Data on a Novel Approach to Treatment of Tobacco Smoking Addiction Using its AERx Essence(R) Nicotine Inhaler
Devices Drug Delivery
 HSMN NewsFeed - 25 Oct 2007
Xencor Expands Series E Financing to $60 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 21 Sep 2007
Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Sep 2007
Aradigm and CyDex Sign Development Collaboration Agreement
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 9 Aug 2007
Nereus Pharmaceuticals Raises $45 Million in Series D-2 Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Jul 2007
SoloSTAR(R), the First Prefilled Disposable Insulin Pen for Lantus(R), is Now Available in the United States
Biopharmaceuticals Endocrinology Drug Delivery
 HSMN NewsFeed - 5 Jul 2007
Aradigm Corporation Names Norman Halleen as Interim Chief Financial Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 3 Jul 2007
Serentis Raises £10.3 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 Jun 2007
New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir(R)
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 5 Jun 2007
Aradigm Names D. Jeffery Grimes as General Counsel and Corporate Secretary
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 1 Jun 2007
FDA Approves Norditropin(R)for Treatment of Short Stature Associated with a Rare Genetic Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Mar 2007
Sapphire Therapeutics, Inc. Promotes William Polvino to CEO, Herb Conrad Elected Chairman of the Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Mar 2007
Amira Pharmaceuticals Raises $25 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Mar 2007
Novo Nordisk Appoints Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Feb 2007
LifeCycle Pharma Appoints Senior Vice President of Pharmaceutical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Feb 2007
Bioenvision Appoints General Manager in Japan
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jan 2007
Aradigm Receives FDA Orphan Drug Designation for Liposomal Ciprofloxacin for Bronchiectasis
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Jan 2007
Novo Nordisk Appoints Nathaniel Clark, M.D., as Senior Medical Advisor - Diabetes
Biopharmaceuticals Endocrinology Personnel
 HSMN NewsFeed - 14 Dec 2006
Novo Nordisk to Pursue Lawsuit Despite Preliminary Injunction Denial
Biopharmaceuticals Litigation
 HSMN NewsFeed - 14 Dec 2006
Court Denies Novo Nordisk's Motion for Preliminary Injunction Against Exubera
Biopharmaceuticals Litigation
 HSMN NewsFeed - 7 Nov 2006
Symphogen Appoints Christian Meyer Vice President of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Oct 2006
NovoSeven(R) Becomes First and Only Recombinant Therapy for Treatment of Rare, Life-Threatening Bleeding Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Oct 2006
Amylin Pharmaceuticals Appoints Joe Young Sr. Vice President, Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Sep 2006
Cubist Pharmaceuticals Appoints Martin Soeters to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Sep 2006
Sapphire Therapeutics, Inc. Licenses Ghrelin Mimetic From Novo Nordisk
Biopharmaceuticals Gastroenterology Surgery Licensing
 HSMN NewsFeed - 18 Sep 2006
Type 2 Diabetes Patients on Technosphere Insulin Exhibited No Adverse Effect on Pulmonary Function with Significant HbA1c Reductions, and Showed Significant Weight Reduction Compared to Injected Insulin Analog
Biopharmaceuticals Drug Delivery Endocrinology
 HSMN NewsFeed - 5 Jul 2006
Aradigm and Novo Nordisk Execute Further Restructuring of Partnership
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 27 Jun 2006
Novo Nordisk Prevails in sanofi-aventis Challenge to Levemir(R) - Up to 24 Hours Duration of Action and Other Claims Upheld
Biopharmaceuticals Litigation
 HSMN NewsFeed - 24 May 2006
AtheroGenics Names Brian Blakey as Vice President of Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 May 2006
Novo Nordisk Announces New Key Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 May 2006
Novo Nordisk Appoints Edward Williams as Vice President of Biopharmaceuticals
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 107

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 107 additional stories matching:
Novo Nordisk
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.